問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
廖育婉
下載
2023-07-01 - 2028-09-30
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting1Sites
Terminated2Sites
2022-11-01 - 2028-04-30
Recruiting3Sites
2024-07-01 - 2027-11-28
Participate Sites8Sites
Recruiting8Sites
2023-10-13 - 2029-12-31
Participate Sites5Sites
Recruiting5Sites
2024-12-02 - 2030-12-09
Participate Sites2Sites
Recruiting2Sites
2024-09-01 - 2026-12-31
xxxxxx
amlitelimab
Efgartigimod PH20 SC
2023-06-01 - 2026-06-08
Dazodalibep
Participate Sites4Sites
Recruiting4Sites
2022-12-14 - 2026-01-01
gout
Epaminurad
Participate Sites13Sites
Not yet recruiting1Sites
Recruiting12Sites
Idiopathic Pulmonary Fibrosis 、Progressive Pulmonary Fibrosis
BI 1015550
Recruiting7Sites
全部
